Compare WGS & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WGS | REAL |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United States | United States |
| Employees | 1300 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Other Specialty Stores |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | N/A | 2019 |
| Metric | WGS | REAL |
|---|---|---|
| Price | $65.76 | $10.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $130.71 | $17.00 |
| AVG Volume (30 Days) | 628.4K | ★ 3.0M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.55 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $692,845,000.00 |
| Revenue This Year | $29.98 | $14.30 |
| Revenue Next Year | $25.92 | $10.19 |
| P/E Ratio | $1,251.58 | ★ N/A |
| Revenue Growth | N/A | ★ 15.38 |
| 52 Week Low | $55.17 | $4.71 |
| 52 Week High | $170.87 | $17.39 |
| Indicator | WGS | REAL |
|---|---|---|
| Relative Strength Index (RSI) | 40.44 | 51.93 |
| Support Level | $61.55 | $9.61 |
| Resistance Level | $95.75 | $11.48 |
| Average True Range (ATR) | 4.01 | 0.52 |
| MACD | 0.81 | 0.23 |
| Stochastic Oscillator | 57.85 | 84.90 |
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.